SPY336.84+0.01 0.00%
DIA279.80+0.38 0.14%
IXIC11,019.30-23.20 -0.21%

Cantor Fitzgerald Maintains Overweight on GW Pharmaceuticals, Lowers Price Target to $174

Cantor Fitzgerald maintains GW Pharmaceuticals (NASDAQ:GWPH) with a Overweight and lowers the price target from $229 to $174.

Benzinga · -

Cantor Fitzgerald maintains GW Pharmaceuticals (NASDAQ:GWPH) with a Overweight and lowers the price target from $229 to $174.